跳至主要内容
临床试验/JPRN-UMIN000020905
JPRN-UMIN000020905已完成2 期

Proof of Concept Test on the efficacy of ultrasonography contrast agent perflurubutane in the differential diagnosis of nodular thyroid lesions - Proof of Concept Test on the efficacy of ultrasonography contrast agent perflurubutane in the differential diagnosis of nodular thyroid lesions

Gunma University Hospital department of nuclear medecine0 个研究点目标入组 10 人开始时间: 2016年2月8日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
10

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1.Patients with a history of hypersensitivity to contents of perflurubutane 2.Patients who are pregnant,possibly pregnant,or nursing 3 Patients with allergies to eggs or egg products 4.Patients with pulmonary arterovenous shunts in the heart or lungs 5.Patients with severe heart or lung disease 6.Patients receiving drug therapy (such as chemotherapy) or radiotherapy for cancer,or will receive such therapy within two days of receiving contrast 7.Patients considered inappropriate for achieving the purpose this clinical study by the principal investigator or investigator.

研究者

发起方
Gunma University Hospital department of nuclear medecine

相似试验